opioid crisis
Specialists petition FDA over opioid approval process
March 22, 2019Medical Communications FDA, approval process, opioid crisis, opioids, painkillers
FDA officials have called on the federal agency to halt the approval of new narcotic painkillers. Dr Sidney Wolfe, a …
Tate art galleries will not accept donations from Sacklers
March 22, 2019Medical Communications OxyContin, Purdue Pharma, Sacklers, Tate, art galleries, opioid crisis
The Tate network of art galleries has said it will no longer accept gifts from the notorious Sackler family, the …
FDA Commissioner Scott Gottlieb announces resignation
March 6, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Scott Gottlieb, opioid crisis, pharma
Dr Scott Gottlieb, the 23rd Commissioner of the US Food and Drug Administration (FDA), stoked surprise throughout the industry with …
OxyContin drugmaker Purdue Pharma exploring bankruptcy, sources say
March 4, 2019Manufacturing and Production Litigation, Purdue Pharma, bankruptcy, opioid crisis, trials
OxyContin drugmaker Purdue Pharma is exploring the option of filing for bankruptcy. The news comes as the Connecticut-based firm faces …
Head of opioid advisory panel criticises FDA for complacency in ongoing crisis
January 28, 2019Medical Communications, Sales and Marketing Dsuvia, FDA, opioid crisis, opioids, pharma
The opioid crisis continues to be a top healthcare concern in the US, but the head of the FDA’s Anesthetic …
Sacklers accused of personally directing deceptive OxyContin sales tactics
January 17, 2019Sales and Marketing OxyContin, Purdue Pharma, opidois, opioid crisis, pain, sackler
Members of the billionaire Sackler dynasty personally directed efforts to mislead doctors and patients as to the dangers of the …
FDA rejects Mallinckrodt’s abuse-deterrent version of opioid painkiller Roxicodone
December 12, 2018Research and Development, Sales and Marketing FDA, Mallinckrodt, Roxicodone, opioid crisis, opioids, pharma
Mallinckrodt has hit a snag in its quest to bring an abuse-deterrent version of Roxicodone (oxycodone hydrochloride) to market in …
FDA approves first prescription mobile app for opioid use disorder, courtesy of Sandoz and Pear Therapeutics
December 11, 2018Manufacturing and Production, Sales and Marketing FDA, Novartis, Pear Therapeutics, app, opioid crisis, opioid epidemic, opioids, pharma, reSET-o
A digital therapeutic launched by Pear Therapeutics and Novartis’ generics and biosimilars division Sandoz has become the first FDA-approved app …
European Commission approves first and only long-acting opioid dependence therapy
November 26, 2018Sales and Marketing Europe, opioid crisis, opioids, pharma
Europe has seen its first and only approval of a long-acting therapy for opioid dependence, as the European Commission (EC) …
Opioid use disorder market to hit $4.8 billion by 2027, says GlobalData
November 26, 2018Sales and Marketing US, opioid crisis, opioids, pharma
New findings released by analytics firm GlobalData indicates that the market for opioid use disorder therapies is set to grow …
Opioid dependency therapy price hiked 600% since 2014, Senate investigators find
November 20, 2018Manufacturing and Production, Sales and Marketing Evzio, Kaleo, Senate, US, naloxone, opioid crisis, opioid epidemic, opioids, pharma
Senate investigators have found that Virginia-based drugmaker Kaleo hiked the price of its opioid dependency therapy Evzio (naloxone) by as …
FDA commissioner Scott Gottlieb says that more rigorous approval process would be unique to opioids
November 12, 2018Sales and Marketing FDA, Gottlieb, opioid crisis, opioids
Food and Drug Administration (FDA) commissioner Scott Gottlieb has said that if a more rigorous approval process is introduced for …
The November 2018 issue of Pharmafocus is available to read online now!
November 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, President trump, Trump, anti vaxxer, brexit, clinical trials, opioid crisis, opioids, pharma, vaccines
As the US continues to battle the demons in its healthcare system, Donald Trump looks like he may finally make …
FDA controversially approves potent opioid up to ten times stronger than fentanyl
November 6, 2018Sales and Marketing Dsuvia, FDA, US, fentanyl, opioid crisis, opioids, pharma
Despite voices of criticism, the FDA has opted to approve AcelRX’s Dsuvia (sufentanil), an opioid medication said to be five …
Trevena’s opioid injection fails to win over FDA committee
October 12, 2018Medical Communications, Sales and Marketing FDA, Trevena, US, oliceridine, opioid, opioid crisis, pharma
Trevena has seen its opioid injection oliceridine fail to win over an FDA advisory panel in the management of acute …
Latest content
FibroFind appoints Lee Borthwick as CEO
